Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
17:28:36 29/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.555 USD | +2.20% |
|
-14.36% | -7.82% |
| 09-21 | Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index | CI |
| 09-18 | William Blair Initiates Perspective Therapeutics With Outperform Rating | MT |
| Market Cap | 285M 252M 238M 216M 405M 27.38B 409M 2.86B 1.1B 13.98B 1.07B 1.05B 45B | P/E 2026 * |
-2.51x | P/E 2027 * | -2.35x |
|---|---|---|---|---|---|
| Enterprise Value | 119M 105M 99.22M 89.98M 169M 11.4B 170M 1.19B 459M 5.82B 446M 436M 18.74B | EV / Sales 2026 * |
400x | EV / Sales 2027 * | 149x |
| Free-Float |
91.77% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CATX | Delayed | |
CBOE
| CATX | Real-time | |
|
Deutsche Boerse AG
| AAJ0 | Delayed | |
|
Tradegate
| AAJ0 | Real-time | |
|
Börse Stuttgart
| AAJ0 | Delayed | |
|
Boerse Muenchen
| AAJ0 | Real-time |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | +2.20% | ||
| 1 week | -14.36% | ||
| Current month | -19.78% | ||
| 1 month | -19.78% | ||
| 3 months | -28.59% | ||
| 6 months | -33.81% | ||
| Current year | -7.82% |
| 1 week | 2.44 |  | 2.92 |
| 1 month | 2.44 | | 3.24 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 04/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 03/09/2025 |
Paul Lyne
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 04/02/2023 |
Lori Woods
CHM | Chairman | 63 | 02/02/2023 |
| Director/Board Member | 60 | 04/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Sell | Company | -167,149 | 0.1464% | ||
| 02/09/26 | Sell | Company | -42,129 | 0.0369% | ||
| 01/09/26 | Sell | Company | -35,769 | 0.0313% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.20% | -14.36% | -24.33% | -7.38% | 285M | |
| -0.03% | +3.77% | +12.35% | +37.22% | 49.06B | |
| -0.81% | -0.58% | +48.59% | +36.48% | 44.6B | |
| -0.17% | +4.19% | +336.17% | +625.96% | 43.24B | |
| -1.34% | -1.62% | +8.80% | +101.32% | 41.73B | |
| +0.34% | -1.38% | +5.53% | +47.36% | 29.93B | |
| +0.72% | -1.62% | +23.81% | +156.06% | 17.19B | |
| -1.99% | +7.69% | +5.80% | - | 15.35B | |
| -3.20% | -3.50% | +25.33% | +42.43% | 15.54B | |
| -1.54% | -4.29% | - | - | 15.11B | |
| Average | -0.64% | +0.01% | +49.12% | +129.93% | 27.2B | |
| Weighted average by Cap. | -0.75% | +2.15% | +72.89% | +163.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 297K 262K 248K 225K 422K 28.52M 426K 2.98M 1.15M 14.56M 1.12M 1.09M 46.86M | 366K 323K 305K 277K 519K 35.09M 524K 3.66M 1.41M 17.92M 1.37M 1.34M 57.67M |
| Net income | -114M -101M -95.59M -86.69M -163M -10.98B -164M -1.15B -442M -5.61B -430M -421M -18.05B | -136M -120M -114M -103M -194M -13.09B -196M -1.37B -526M -6.68B -512M -501M -21.5B |
| Net Debt | -167M -147M -139M -126M -236M -15.98B -239M -1.67B -643M -8.16B -625M -612M -26.26B | -231M -204M -193M -175M -328M -22.15B -331M -2.31B -891M -11.31B -867M -848M -36.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | US$2.535 | +1.40% | 671,077 |
| 28/09/26 | US$2.500 | -0.79% | 1,504,853 |
| 25/09/26 | US$2.520 | +0.80% | 1,801,824 |
| 24/09/26 | US$2.500 | -4.58% | 1,698,409 |
| 23/09/26 | US$2.620 | -11.49% | 3,161,056 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
